Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
2613 studies found for:    vaccines | Child
Show Display Options
Rank Status Study
1 Active, not recruiting Exploration of the Biologic Basis for Underperformance of Oral Polio and Rotavirus Vaccines in INDIA (PROVIDE)
Conditions: Poliomyelitis;   Tropical Enteropathy
Intervention: Biological: IPV vaccination
2 Completed
Has Results
Safety, Tolerability and Immunogenicity of Two Different Formulations of Meningococcal B Recombinant Vaccine, When Administered to Healthy Infants
Condition: Meningococcal Disease
Interventions: Biological: rMenB;   Biological: rMenB+OMV
3 Completed Safety and Immunogenicity of 2 Commercially Available Influenza Vaccines in Children
Condition: Influenza
Intervention: Biological: Influenza vaccine
4 Active, not recruiting A Cohort Study to Assess Sustained Immunogenicity to qHPV Vaccine Among HIV-infected Girls and Boys Age 9-14 Years
Conditions: Human Papillomavirus;   HIV-1 Infection
Intervention: Biological: Gardasil vaccine
5 Completed Persistence of Antibodies and Kinetics of B Cell Response in Healthy Children After Vaccination With MCC Vaccine
Condition: Prevention of Meningococcal Infection
Intervention: Biological: Meningococcal C conjugate vaccine
6 Unknown  Trial of Additional Measles Vaccine to Reduce Child Mortality
Condition: Measles Vaccine
Intervention: Biological: Early measles vaccine
7 Completed A Phase I/II Trial of a Tetravalent Live Attenuated DEN Vaccine in Flavivirus Antibody Naive Children
Condition: Dengue
Intervention: Biological: DEN vaccine F17
8 Completed Immunogenicity of a JE-CV as a Booster Dose After a Primary Vaccination With SA14-14-2 Vaccine
Condition: Japanese Encephalitis
Intervention: Biological: a live attenuated chimeric JE vaccine
9 Completed Evaluation of Meningococcal C Vaccine Programmes in Canadian Children
Condition: Meningococcal Sero-type C Infection
Intervention: Biological: NeisVac C vaccine (12mth)
10 Withdrawn Safety and Immunogenicity of EV71 Vaccine With or Without Aluminum Adjuvant in Infants
Condition: Infection, Viral, Enterovirus
Intervention: Biological: 400 U EV71 vaccine with adjuvant
11 Not yet recruiting Safety Study of Enterovirus 71 Vaccine in Children Aged 6-35 Months Old
Condition: Enterovirus 71 Vaccine
Intervention: Biological: two doses enterovirus 71 vaccine
12 Completed School Influenza Vaccine vs Standard of Care With Nested Trial of 2 Parent Notification Intensities
Conditions: Immunizations;   Vaccination;   Influenza;   School Health
Interventions: Behavioral: School based flu vaccine: Low intensity;   Behavioral: School based flu vaccine: High intensity
13 Completed Immunogenocity and Safety of Flubio (Influenza HA) Vaccine in Infants and Children (Bridging Study)
Condition: Healthy
Intervention: Biological: Vaccine
14 Completed
Has Results
Persistence of Antibody Levels and Response to Fifth or Third Meningococcal B Recombinant Vaccine in 4-year Old Healthy Children Who Previously Participated in Study V72P12E1
Conditions: Meningococcal Disease;   Meningococcal Meningitis
Interventions: Biological: 1 dose of Meningococcal (group B) multicomponent recombinant adsorbed vaccine;   Biological: 2 doses of Meningococcal (group B) multicomponent recombinant adsorbed vaccine
15 Completed
Has Results
Safety and Immunogenicity of Meningococcal ACWY Conjugate Versus Polysaccharide Vaccine in Children 2 to 10 Years of Age
Condition: Meningococcal Disease
Interventions: Biological: Meningococcal ACWY-CRM conjugate vaccine;   Biological: Meningococcal ACWY-PS polysaccharide vaccine
16 Completed Immunogenicity and Safety Following a Single Dose of Influenza Vaccines in Healthy Children Who Received Either One or the Other Vaccine (an Adjuvanted Sub-unit Influenza Vaccine and a Non-adjuvanted Split Virion Influenza Vaccine) in the Previous V70P2 Study
Condition: FLU
Intervention: Biological: Influenza Trivalent Inactivated Vaccines
17 Completed Safety and Immunogenicity of Inactivated Influenza Virus Vaccine Among Healthy Children 6-12 Weeks of Age
Condition: Inactivated Influenza Vaccine
Intervention: Biological: 2005-2006 trivalent inactivated influenza vaccine
18 Completed
Has Results
Safety and Immunogenicity of Rotavirus Vaccine (RotaTeq(R)) in Infants With Short Bowel Syndrome
Condition: Short Bowel Syndrome
Intervention: Biological: Oral, live, pentavalent rotavirus vaccine; RotaTeq(R)
19 Completed
Has Results
Persistence of Immunogenicity of MenACWY Conjugate Vaccine 5 Years After Childhood Vaccination, and Immune Response to a Booster Dose
Condition: Meningococcal Disease
Intervention: Biological: Meningococcal (groups A, C, W, and Y) oligosaccharide diphtheria CRM-197 conjugate vaccine
20 Completed PCV7 in the Prevention of Nasopharyngeal Carriage of Vaccine Serotype (VT) Streptococcus Pneumoniae
Conditions: Streptococcal Pneumonia;   Nasopharyngeal Diseases;   Vaccination Adverse Event
Interventions: Biological: PCV7 (Pneumococcal 7-Valent Conjugate Vaccine);   Biological: Hib Vaccine

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.